Abiopharma

BioVie Announces Topline Results of Phase 2 SUNRISE-PD Trial of Bezisterim in Early Parkinson’s Disease

MariMed Embraces Pumpkin Season By Unveiling New Products That Bring Seasonal Autumn Flavors to Cannabis Consumers

Genie Energy Announces Second Quarter 2026 Results

Collegium Reports Second Quarter 2026 Financial Results and Highlights Recent Company Progress

Nova Reports Record Second Quarter 2026 Financial Results

Compass Therapeutics Reports 2026 Second Quarter Financial Results and Provides Corporate Update

Abeona Therapeutics® to Host Second Quarter 2026 Financial Results Conference Call on August 13, 2026

LTM Collaborates with Chainguard to Strengthen Software Supply Chain Security through BlueVerse™ RightLogic

EuroDry Ltd. Reports Results for the Quarter and Six-Month Period Ended June 30, 2026

NETSCOUT Reports First Quarter Fiscal Year 2027 Financial Results

Nayax Files Application to Establish Nayax America Bank in the United States

F&G Annuities & Life Declares Dividends on Common and Preferred Stock

Les cellules HPQ ENDURA+ GEN4 21700 obtiennent la certification UN 38.3; les activités de qualification auprès des clients progressent

Installed Building Products Reports Second Quarter 2026 Results; Declares Regular Quarterly Cash Dividend

HPQ ENDURA+ GEN4 21700 Cells Achieve UN 38.3 Certification Supports Ongoing Customer Qualification Activities